Get the Stockscreener App
0.3176
5.19%
-0.0174
After Hours:
.32
0.0024
+0.76%
Cosmos Health Inc stock is traded at $0.3176, with a volume of 191.98K.
It is down -5.19% in the last 24 hours and down -34.65% over the past month.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
See More
Previous Close:
$0.335
Open:
$0.3455
24h Volume:
191.98K
Relative Volume:
0.48
Market Cap:
$7.95M
Revenue:
$56.04M
Net Income/Loss:
$-20.39M
P/E Ratio:
-0.1302
EPS:
-2.44
Net Cash Flow:
$-6.84M
1W Performance:
-7.13%
1M Performance:
-34.65%
6M Performance:
-57.20%
1Y Performance:
-34.35%
1-Day Range:
$0.2801
$0.3455
1-Week Range:
$0.2801
$0.39
52-Week Range:
$0.2801
$1.58
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3176 | 7.95M | 56.04M | -20.39M | -6.84M | -2.44 |
|
MCK
Mckesson Corporation
|
682.49 | 85.55B | 344.58B | 2.83B | 1.63B | 21.84 |
|
COR
Cencora Inc
|
281.16 | 55.07B | 303.19B | 1.40B | -638.10M | 7.03 |
|
CAH
Cardinal Health Inc
|
131.17 | 32.56B | 222.16B | 1.31B | -486.00M | 5.36 |
|
HSIC
Henry Schein Inc
|
63.08 | 8.04B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
6.51 | 534.60M | 10.42B | -38.77M | 323.54M | -0.51 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health Reports Full-Year 2024 Results: Revenue - GlobeNewswire
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million | COSM Stock News - GuruFocus
Cosmos Health Inc. Reports Year-End 2024 Financial Results Highlighting Revenue Growth and Strategic Developments - Nasdaq
Cosmos Health Inc. SEC 10-K Report - TradingView
Cosmos Health Further Expands Facility Upgrades Program at Cana - GuruFocus
Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins - ACCESS Newswire
Cosmos Health secures deal for antiseptic drug production By Investing.com - Investing.com South Africa
Cosmos Health secures deal for antiseptic drug production - Investing.com
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L - GlobeNewswire
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract… - Informazione.it
Massive Deal: Cosmos Health Secures 5-Year Contract for 1.5M Antiseptic Drug Units - Stock Titan
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Cosmos Health expands into Albania with new supplement brand - Investing.com
Cosmos Health expands into Albania with new supplement brand By Investing.com - Investing.com South Africa
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order - The Manila Times
Cosmos Health Launches Sky Premium Life in Albania through - GlobeNewswire
Cosmos Health Lands Major $300K Deal in Strategic Albanian Market Entry - Stock Titan
Cosmos Holdings stock hits 52-week low at $0.34 amid market challenges - Investing.com India
Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants - ACCESS Newswire
Cosmos Holdings stock hits 52-week low at $0.44 By Investing.com - Investing.com South Africa
Cosmos Holdings stock hits 52-week low at $0.44 - Investing.com India
Cosmos Health CEO acquires $44,999 in stock through debt exchange By Investing.com - Investing.com South Africa
Cosmos Health CEO acquires $44,999 in stock through debt exchange - Investing.com
Cosmos Holdings stock hits 52-week low at $0.46 - Investing.com India
Cosmos health CEO acquires shares worth $65,000 in debt exchange By Investing.com - Investing.com South Africa
Cosmos health CEO acquires shares worth $65,000 in debt exchange - Investing.com
Cosmos Health CEO Acquires Over 130K Shares Through Debt Exchange - TradingView
Cosmos Health Inc. (NASDAQ:COSM) Might Not Be As Mispriced As It Looks After Plunging 31% - simplywall.st
Cosmos Holdings stock hits 52-week low at $0.46 By Investing.com - Investing.com Canada
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company - ACCESS Newswire
Cosmos Health expands distribution of Avian Influenza kits - MSN
Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split - ACCESS Newswire
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - ACCESS Newswire
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock By Investing.com - Investing.com Canada
Cosmos Health CEO Grigorios Siokas acquires $200,000 in stock - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange Agreement - TradingView
Tuesday 2/25 Insider Buying Report: COSM, SEPN - Nasdaq
Bullish Cosmos Health Insiders Loaded Up On US$539.0k Of Stock - Yahoo Finance
Cosmos Health postpones securities offering By Investing.com - Investing.com South Africa
Cosmos Health postpones securities offering - Investing.com India
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - ACCESS Newswire
Strategic Shift: Cosmos Health Postpones Capital Raise, Prioritizes Annual Report - StockTitan
Cosmos Health Inc. (NASDAQ:COSM) Short Interest Down 39.7% in January - Defense World
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.63%
2.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):